Skip to main content
. 2020 Jan 3;69(3):383–397. doi: 10.1007/s00262-019-02456-z

Table 2.

Immune biomarkers were evaluated at baseline and compared across the two study groups

Immune biomarker SOC + oregovomab SOC p valuea
N Median Min–max N Median Min–max
Number of CA125-specific IFN-γ+CD8+ T lymphocytes/ml 17 0.00 0.00–4682 20 0.00 0.00–1114 n.s.
Number of MDSC4/ml 23 181,407 3610–757,390 24 117,045 21,080–300,960 n.s.
Number of Treg/ml 25 56,440 11,319–89,041 26 55,420 21,080–130,967 n.s.
NMLR 36 3.046 1.338–10.32 35 2.925 1.426–11.375 n.s.

p values ≥ 0.05 were considered not significant (n.s.)

aBy Mann–Whitney U test